发明名称 |
CMP-DEPENDENT SIALIDASE ACTIVITY |
摘要 |
The present disclosure is directed to the properties of certain glycosyltransferase variants having N-terminal truncation deletions or internal deletions. Any of the mutants disclosed in here exhibit α-2,6-sialyltransferase enzymatic activity in the presence of CMP-activated sialic acid as co-substrate, and in the presence of a suitable acceptor site. A fundamental finding documented in the present disclosure is that suchs enzyme are not only capable of catalyzing transfer of a sialidyl moiety but they are also capable of catalyzing hydrolytic cleavage of terminally bound sialic acid from a glycan. Particularly it was found that in the presence of cytidine 5'-monophosphate (CMP) glycosyltransferase activity is inhibited, and sialidase activity is stimulated. Sialidase activity was found to be dependent on the presence of a particular stretch of amino acids (position 90 to 108) in the polypeptide sequence of the reference (wildtype) hST6Gal-I polypeptide. Deletion of this sequence portion in an N-terminal truncation variant was found to abolish sialidase activity, notably both in the presence and in the absence of CMP. Thus, disclosed are compositions, uses and methods employing the CMP-mediated feed-back regulation documented herein. |
申请公布号 |
WO2016102436(A1) |
申请公布日期 |
2016.06.30 |
申请号 |
WO2015EP80741 |
申请日期 |
2015.12.21 |
申请人 |
F. HOFFMANN-LA ROCHE AG;ROCHE DIAGNOSTICS GMBH;ROCHE DIAGNOSTICS OPERATIONS, INC. |
发明人 |
SOBEK, HARALD;GREIF, MICHAEL;THOMANN, MARCO;MALIK, SEBASTIAN |
分类号 |
C12N9/10;C12P19/44 |
主分类号 |
C12N9/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|